Details of the Drug Reposition

General Information of This Drug (ID: DML2VSZ)

Drug Name
H3B-8800   DML2VSZ

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic myelogenous leukaemia DIS0301E 2A20.0 Phase 1 [1]
Myelodysplastic syndrome DISYHNUI 2A37 Phase 1 [2]
Chronic myelomonocytic leukaemia DISDN5P7 2A40 Phase 1 [2]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02841540) A Study of H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia. U.S. National Institutes of Health.